pyrazinamide has been researched along with Agranulocytosis in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mühlberger, F | 1 |
Rabina, EV | 1 |
Semichastnova, AG | 1 |
Golubiatnikova, GA | 1 |
2 other studies available for pyrazinamide and Agranulocytosis
Article | Year |
---|---|
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hyp | 1973 |
[Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
Topics: Aged; Agranulocytosis; Antitubercular Agents; Carcinoma, Hepatocellular; Chemical and Drug Induced L | 1972 |